Axonics Modulation Technologies Valuation

Axonics Modulation Investor Information

About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.1. Axonics Modulation had not issued any dividends in recent years. Based on the analysis of Axonics Modulation's profitability, liquidity, and operating efficiency, Axonics Modulation Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Axonics Modulation Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Axonics suggests not a very effective usage of assets in December.

Axonics Modulation Ownership Allocation

Axonics Modulation holds a total of 51.11 Million outstanding shares. The majority of Axonics Modulation Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axonics Modulation to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axonics Modulation. Please pay attention to any change in the institutional holdings of Axonics Modulation Technologies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Axonics Modulation Profitability Analysis

The company reported the previous year's revenue of 366.38 M. Net Loss for the year was (6.09 M) with profit before overhead, payroll, taxes, and interest of 197.66 M.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.